Transatlantic VC Fund Takes Aim at Rare Disease Space
By Nuala Moran
Wednesday, June 26, 2013
LONDON European and U.S. investors are joining forces to launch the first venture capital fund dedicated solely to investing in treatments for rare diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.